Evidence map›Paper›PMID 42795060›Full record

ReviewMaterials (Basel, Switzerland)2026

Multiscale Mechanisms and a Mechanism-Oriented Evaluation Framework for Warm-Mix Asphalt.

Xin Zhang, Ya Lu, Xinhai Liu

Abstract readReview
In one paragraph

Review in Materials (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Xin ZhangSchool of Smart City Construction and Digital Twin, Chongqing Institute of Engineering, Chongqing 400056, China.
Ya LuSchool of Smart City Construction and Digital Twin, Chongqing Institute of Engineering, Chongqing 400056, China.
Xinhai LiuGuangdong Jiaoke Technology Development Co., Ltd., Guangzhou 510550, China.

Funding

Chongqing Municipality Education Commission KJQN202301908Chongqing Municipality Education Commission KJQN202301909Guangdong Provincial Communications Group JT2023YB12Talent Introduction Program of Chongqing Institute of Engineering 2021gcky01
6 · The paper itself

Abstract

Warm-mix asphalt (WMA) reduces mixing and compaction temperatures through wax additives, chemical additives, and foaming techniques, but their dominant mechanisms, performance trade-offs, and evaluation priorities differ. This structured narrative review synthesizes evidence for Sasobit, Evotherm, and Advera as representative technologies across mixture, binder and mastic, interfacial and microstructural, and molecular scale. Sasobit-type wax additives improve construction-stage fluidity and high-temperature stability through viscosity-temperature regulation and wax crystallization, while low-temperature and fatigue risks require attention. Evotherm-type chemical additives enhance wetting and moisture resistance through surface-active adsorption, thin-film lubrication, and improved interfacial adhesion, with high-temperature shear resistance requiring verification. Advera-type zeolite foaming extends the compaction window through water release and microbubble formation, but residual moisture and wet-condition durability remain critical concerns. On this basis, technology-specific cross-scale evidence chains are established, and a mechanism-oriented evaluation framework is proposed, linking engineering scenarios, dominant mechanisms, reduced-temperature mix design feasibility, durability constraints, and applicability assessment. Mixture performance serves as the final criterion, while binder and interfacial evidence supports risk screening and molecular evidence provides mechanistic interpretation. The framework supports targeted material selection, experimental design, risk diagnosis, and process optimization.

Indexed as

cross-scale evidence chainmechanism-oriented evaluation frameworkmultiscale mechanismsWMA

Identifiers

PMID42795060
PMCPMC13608354

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.